<?xml version="1.0" encoding="UTF-8"?><faers xmlns="http://fda.gov/ns/faers"><meta><status>PENDING</status><version>v2</version><patient-age>51</patient-age><report-id>BR-AMGEN-BRASP2012021709</report-id><gender>female</gender><reactions><reaction>Felt very bad</reaction><reaction>patient felt a lot of burning</reaction><reaction>patient was presenting a cyst in her kidney, which got increased</reaction><reaction>Urinary infections very strong</reaction><reaction>Headaches</reaction><reaction>pains over the body</reaction><reaction>Secretion when patient coughs</reaction><reaction>Nose congested</reaction><reaction>left ear buzzing</reaction><reaction>difficulty to listen</reaction><reaction>pain in the application site</reaction></reactions><drugs><drug><ndc>59572983</ndc><drug-name>Enbrel</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>METICORTEN</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>TECNOMET                           /00113801/</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>PREDNISONE</drug-name><manufacturer/><ingredients/></drug></drugs><indications><indication>Rheumatoid arthritis</indication></indications><patient-age>51</patient-age><outcomes><outcome>Required Inpatient Hospitalization</outcome></outcomes><country>Brazil</country><geo/></meta><original><ichicsr lang="en" xmlns="">
	<ichicsrmessageheader>
		<messagetype>ichicsr</messagetype>
		<messageformatversion>2.1</messageformatversion>
		<messageformatrelease>2.0</messageformatrelease>
		<messagenumb>864710_123</messagenumb>
		<messagesenderidentifier>AMGENSAFETY</messagesenderidentifier>
		<messagereceiveridentifier>ZZFDA</messagereceiveridentifier>
		<messagedateformat>204</messagedateformat>
		<messagedate>20130125151405</messagedate>
	</ichicsrmessageheader>
	<safetyreport>
		<safetyreportversion>2</safetyreportversion>
		<safetyreportid>BR-AMGEN-BRASP2012021709</safetyreportid>
		<primarysourcecountry>BR</primarysourcecountry>
		<occurcountry>BR</occurcountry>
		<transmissiondateformat>102</transmissiondateformat>
		<transmissiondate>2013-01-25</transmissiondate>
		<reporttype>1</reporttype>
		<serious code="1">Yes</serious>
		<seriousnessdeath>2</seriousnessdeath>
		<seriousnesslifethreatening>2</seriousnesslifethreatening>
		<seriousnesshospitalization>1</seriousnesshospitalization>
		<seriousnessdisabling>2</seriousnessdisabling>
		<seriousnesscongenitalanomali>2</seriousnesscongenitalanomali>
		<seriousnessother>1</seriousnessother>
		<receivedateformat>102</receivedateformat>
		<receivedate>2012-04-02</receivedate>
		<receiptdateformat>102</receiptdateformat>
		<receiptdate>2013-01-16</receiptdate>
		<additionaldocument>1</additionaldocument>
		<documentlist>E2B Differences Report</documentlist>
		<fulfillexpeditecriteria>1</fulfillexpeditecriteria>
		<companynumb>BR-PFIZER INC-2012084377</companynumb>
		<duplicate>1</duplicate>
		<reportduplicate>
			<duplicatesource>PFIZER INC</duplicatesource>
			<duplicatenumb>BR-PFIZER INC-2012084377</duplicatenumb>
		</reportduplicate>
		<primarysource>
			<reporterfamilyname>PRIVACY</reporterfamilyname>
			<reportercountry>BR</reportercountry>
			<qualification code="5">Consumer or non-health professional</qualification>
		</primarysource>
		<sender>
			<sendertype>1</sendertype>
			<senderorganization>AMGENSAFETY</senderorganization>
			<senderdepartment>Amgen Global Safety</senderdepartment>
			<sendergivename>Paul</sendergivename>
			<senderfamilyname>Eisenberg</senderfamilyname>
			<senderstreetaddress>One Amgen Center Drive</senderstreetaddress>
			<sendercity>Thousand Oaks</sendercity>
			<senderstate>California</senderstate>
			<senderpostcode>91320</senderpostcode>
			<sendercountrycode>US</sendercountrycode>
			<sendertel>8054471000</sendertel>
			<sendertelcountrycode>1</sendertelcountrycode>
			<senderfax>8054994495</senderfax>
			<senderfaxcountrycode>1</senderfaxcountrycode>
			<senderemailaddress>dsstriage@amgen.com</senderemailaddress>
		</sender>
		<receiver>
			<receivertype>2</receivertype>
			<receiverorganization>ZZFDA</receiverorganization>
			<receivergivename>Bill</receivergivename>
			<receiverfamilyname>Taylor</receiverfamilyname>
			<receivercountrycode>US</receivercountrycode>
			<receiveremailaddress>wtaylor@oc.fda.gov</receiveremailaddress>
		</receiver>
		<patient>
			<patientinitial>PRIVACY</patientinitial>
			<patientonsetage>51</patientonsetage>
			<patientonsetageunit>801</patientonsetageunit>
			<patientagegroup>5</patientagegroup>
			<patientweight>60</patientweight>
			<patientheight>153</patientheight>
			<patientsex code="2">Female</patientsex>
			<resultstestsprocedures>Unspecified exams (Sep2012): urinary infections very strong.
Tomography with contrast (unspecified date): unspecified results</resultstestsprocedures>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Rheumatoid arthritis</patientepisodename>
				<patientmedicalcontinue>1</patientmedicalcontinue>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Hypertension</patientepisodename>
			</medicalhistoryepisode>
			<reaction>
				<primarysourcereaction>Felt very bad</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Feeling bad</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Feeling abnormal</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>patient felt a lot of burning</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Burning sensation</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Burning sensation</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>patient was presenting a cyst in her kidney, which got increased</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Renal cyst</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Renal cyst</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionoutcome code="3">not recovered/not resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Urinary infections very strong</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Urinary infection</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Urinary tract infection</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Headaches</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Headache</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Headache</reactionmeddrapt>
				<termhighlighted>1</termhighlighted>
				<reactionoutcome code="3">not recovered/not resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>pains over the body</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>General body pain</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Pain</reactionmeddrapt>
				<termhighlighted>1</termhighlighted>
				<reactionoutcome code="3">not recovered/not resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Secretion when patient coughs</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Secretion discharge</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Secretion discharge</reactionmeddrapt>
				<termhighlighted>1</termhighlighted>
				<reactionoutcome code="3">not recovered/not resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Secretion when patient coughs</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Cough</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Cough</reactionmeddrapt>
				<termhighlighted>1</termhighlighted>
				<reactionoutcome code="3">not recovered/not resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Nose congested</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Nose congestion</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Nasal congestion</reactionmeddrapt>
				<termhighlighted>1</termhighlighted>
				<reactionoutcome code="3">not recovered/not resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>left ear buzzing</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Ear buzzing</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Tinnitus</reactionmeddrapt>
				<termhighlighted>1</termhighlighted>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>difficulty to listen</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Hearing impaired</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Hearing impaired</reactionmeddrapt>
				<termhighlighted>1</termhighlighted>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>pain in the application site</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Injection site pain</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Injection site pain</reactionmeddrapt>
				<termhighlighted>1</termhighlighted>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>Enbrel</medicinalproduct>
				<obtaindrugcountry>US</obtaindrugcountry>
				<drugauthorizationnumb>103-795</drugauthorizationnumb>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugauthorizationholder>Amgen</drugauthorizationholder>
				<drugstructuredosagenumb>50</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>1</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="803">Week</drugintervaldosagedefinition>
				<drugdosagetext>50 mg, once weekly</drugdosagetext>
				<drugdosageform normalized="powder and solvent for solution for injection">Powder and solvent for solution for injection</drugdosageform>
				<drugadministrationroute code="058">Subcutaneous</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Rheumatoid arthritis</drugindication>
				<drugstartdateformat>610</drugstartdateformat>
				<drugstartdate>2012-01-01</drugstartdate>
				<actiondrug code="4">Dose not changed</actiondrug>
				<activesubstance>
					<activesubstancename>etanercept</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Burning sensation</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Provided</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Cough</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Provided</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Feeling abnormal</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Provided</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Headache</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Provided</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Hearing impaired</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Provided</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Injection site pain</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Provided</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Nasal congestion</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Provided</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Pain</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Provided</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Renal cyst</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Provided</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Secretion discharge</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Provided</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Tinnitus</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Provided</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Urinary tract infection</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Provided</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>Enbrel</medicinalproduct>
				<obtaindrugcountry>US</obtaindrugcountry>
				<drugauthorizationnumb>103-795</drugauthorizationnumb>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugauthorizationholder>Amgen</drugauthorizationholder>
				<drugstructuredosagenumb>25</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>2</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="803">Week</drugintervaldosagedefinition>
				<drugdosagetext>25 mg, 2x/week</drugdosagetext>
				<drugdosageform normalized="powder and solvent for solution for injection">Powder and solvent for solution for injection</drugdosageform>
				<drugadministrationroute code="058">Subcutaneous</drugadministrationroute>
				<drugstartdateformat>610</drugstartdateformat>
				<drugstartdate>2012-03-01</drugstartdate>
				<actiondrug code="4">Dose not changed</actiondrug>
				<activesubstance>
					<activesubstancename>etanercept</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Burning sensation</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Provided</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Cough</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Provided</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Feeling abnormal</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Provided</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Headache</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Provided</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Hearing impaired</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Provided</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Injection site pain</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Provided</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Nasal congestion</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Provided</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Pain</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Provided</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Renal cyst</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Provided</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Secretion discharge</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Provided</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Tinnitus</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Provided</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Urinary tract infection</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Provided</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>Enbrel</medicinalproduct>
				<obtaindrugcountry>US</obtaindrugcountry>
				<drugauthorizationnumb>103-795</drugauthorizationnumb>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugauthorizationholder>Amgen</drugauthorizationholder>
				<drugdosagetext>UNK</drugdosagetext>
				<drugdosageform normalized="powder and solvent for solution for injection">Powder and solvent for solution for injection</drugdosageform>
				<actiondrug code="4">Dose not changed</actiondrug>
				<activesubstance>
					<activesubstancename>etanercept</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Burning sensation</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Provided</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Cough</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Provided</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Feeling abnormal</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Provided</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Headache</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Provided</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Hearing impaired</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Provided</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Injection site pain</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Provided</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Nasal congestion</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Provided</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Pain</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Provided</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Renal cyst</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Provided</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Secretion discharge</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Provided</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Tinnitus</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Provided</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Urinary tract infection</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Not Provided</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>METICORTEN</medicinalproduct>
				<drugseparatedosagenumb>1</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>unknown dose, once daily</drugdosagetext>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Rheumatoid arthritis</drugindication>
				<activesubstance>
					<activesubstancename>PREDNISONE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>TECNOMET                           /00113801/</medicinalproduct>
				<drugdosagetext>UNK</drugdosagetext>
				<activesubstance>
					<activesubstancename>METHOTREXATE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>PREDNISONE</medicinalproduct>
				<drugdosagetext>UNK</drugdosagetext>
				<activesubstance>
					<activesubstancename>PREDNISONE</activesubstancename>
				</activesubstance>
			</drug>
			<summary>
				<narrativeincludeclinical>This is a spontaneous report from a contactable consumer (patient) from the non clinical study program Muito Bem Vindo. This 51-year old, female patient started to receive <Semaphore x="545709" class="Medicine" value="Etanercept" score="0.99" ID="247557">etanercept </Semaphore>(<Semaphore x="528270" class="Medicine" value="Enbrel" score="0.87" ID="248473">ENBREL</Semaphore>), Powder and solvent for solution for <Semaphore x="2057274" class="AnatomicStructure" value="Injection Site" score="1.00" ID="C77680">injection</Semaphore>, via subcutaneous route of administration, since approximately Mar2012 at 25 mg twice weekly for <Semaphore x="2469205" class="Disease or Finding" value="Rheumatoid Arthritis" score="1.00" ID="C2884">rheumatoid arthritis</Semaphore>. The patient also received <Semaphore x="545709" class="Medicine" value="Etanercept" score="0.99" ID="247557">etanercept </Semaphore>(<Semaphore x="528270" class="Medicine" value="Enbrel" score="0.87" ID="248473">ENBREL </Semaphore><Semaphore x="2425244" class="Disease or Finding" value="Progression of Multiple Myeloma or Plasma Cell Leukemia" score="1.00" ID="C70643">PFS</Semaphore>), Solution for <Semaphore x="2057274" class="AnatomicStructure" value="Injection Site" score="1.00" ID="C77680">injection </Semaphore>in pre filled pen, via subcutaneous route of administration, since Jan2012 to an unspecified date at 50 mg, once weekly<Semaphore x="2469205" class="Disease or Finding" value="Rheumatoid Arthritis" score="1.00" ID="C2884">, for <Semaphore x="2469205" class="Disease or Finding" value="Rheumatoid Arthritis" score="1.00" ID="C2884">rheumatoid arthritis</Semaphore></Semaphore>. Medical history included <Semaphore x="2038093" class="Disease or Finding" value="Hypertension" score="1.00" ID="C3117">hypertension </Semaphore>from an unknown date and unknown if ongoing. Concomitant medications included <Semaphore x="1081881" class="Medicine" value="predniSONE" score="0.87" ID="291353">prednisone </Semaphore>(METICORTEN) since an unknown date, at unknown dose once daily for <Semaphore x="2469205" class="Disease or Finding" value="Rheumatoid Arthritis" score="1.00" ID="C2884">rheumatoid arthritis </Semaphore>and <Semaphore x="861252" class="Medicine" value="Methotrexate" score="0.74" ID="279493">methotrexate </Semaphore>(TECNOMET) since an unknown date at an unknown dose for an unknown indication and <Semaphore x="1081881" class="Medicine" value="predniSONE" score="0.87" ID="291353">prednisone </Semaphore>since an unknown date at an unspecified posology for an unknown indication. Both <Semaphore x="861252" class="Medicine" value="Methotrexate" score="0.74" ID="279493">methotrexate </Semaphore>(TECNOMET) and <Semaphore x="1081881" class="Medicine" value="predniSONE" score="0.87" ID="291353">prednisone </Semaphore>were ongoing at events onset, but it was unspecified if they were ongoing on 08Jan2013. The patient informed that she has been on <Semaphore x="545709" class="Medicine" value="Etanercept" score="0.99" ID="247557">etanercept</Semaphore>, Powder and solvent for solution for <Semaphore x="2057274" class="AnatomicStructure" value="Injection Site" score="1.00" ID="C77680">injection </Semaphore>but since Jan2012 she has been on <Semaphore x="545709" class="Medicine" value="Etanercept" score="0.99" ID="247557">etanercept</Semaphore>, Solution for <Semaphore x="2057274" class="AnatomicStructure" value="Injection Site" score="1.00" ID="C77680">injection </Semaphore>in pre filled pen. After she had performed the application with <Semaphore x="545709" class="Medicine" value="Etanercept" score="0.99" ID="247557">etanercept</Semaphore>, Solution for <Semaphore x="2057274" class="AnatomicStructure" value="Injection Site" score="1.00" ID="C77680">injection </Semaphore>in pre filled pen, she <Semaphore x="1976621" class="Procedure" value="Get Headaches" score="1.00" ID="C111065">has been experiencing <Semaphore x="2008813" class="Disease or Finding" value="Headache" score="1.00" ID="C34661">headaches</Semaphore></Semaphore>, <Semaphore x="2920343" class="MedDRA LLT" value="Ear pain" score="1.00" ID="10014020"><Semaphore x="2365183" class="Disease or Finding" value="Pain" score="1.00" ID="C3303"><Semaphore x="1871541" class="Disease or Finding" value="Ear Pain" score="1.00" ID="C37944">pain and <Semaphore x="2101485" class="AnatomicStructure" value="Left Ear" score="1.00" ID="C81259"><Semaphore x="1872213" class="AnatomicStructure" value="Ear" score="1.00" ID="C12394">left <Semaphore x="3280567" class="MedDRA LLT" value="Tinnitus" score="1.00" ID="10043882">ear </Semaphore></Semaphore>
        </Semaphore>
       </Semaphore>
      </Semaphore>
     </Semaphore>
    <Semaphore x="3280567" class="MedDRA LLT" value="Tinnitus" score="1.00" ID="10043882">buzzing </Semaphore>which caused difficulty to listen. Additionally, the patient also <Semaphore x="2005619" class="Procedure" value="Have Pain" score="1.00" ID="C91126">has been feeling <Semaphore x="2757074" class="MedDRA LLT" value="Application site pain" score="1.00" ID="10003051">pain </Semaphore></Semaphore>
    <Semaphore x="2757074" class="MedDRA LLT" value="Application site pain" score="1.00" ID="10003051">in the <Semaphore x="1541394" class="AnatomicStructure" value="Application Site" score="1.00" ID="C77676">application site</Semaphore></Semaphore>. She also experienced <Semaphore x="1609977" class="Disease or Finding" value="Bodily Pain" score="1.00" ID="C114901"><Semaphore x="3167117" class="MedDRA LLT" value="Pain" score="1.00" ID="10033371">pains </Semaphore>over the body</Semaphore>, secretion when <Semaphore x="2884277" class="MedDRA LLT" value="Cough" score="1.00" ID="10011224">coughing </Semaphore>and congested <Semaphore x="2320472" class="AnatomicStructure" value="Nose" score="1.00" ID="C12756">nose</Semaphore>. In follow up on 04Jan2013 the patient further reported that on 27Sep2012 she stayed 3 days hospitalized because she presented with <Semaphore x="1861243" class="Disease or Finding" value="Dizziness" score="1.00" ID="C37943">dizziness </Semaphore>and <Semaphore x="1932946" class="Disease or Finding" value="Fever" score="1.00" ID="C3038">fever</Semaphore>. She informed that during the <Semaphore x="3012166" class="MedDRA LLT" value="Hospitalisation" score="1.00" ID="10054112">hospitalization </Semaphore>she underwent exams and she was <Semaphore x="1846062" class="Procedure" value="Diagnosis" score="1.00" ID="C15220">diagnosed </Semaphore>as having <Semaphore x="3299128" class="MedDRA LLT" value="Urinary tract infection" score="1.00" ID="10046571"><Semaphore x="2088512" class="AnatomicStructure" value="Kidney" score="1.00" ID="C12415">urinary </Semaphore>infections </Semaphore>very strong, presented with <Semaphore x="1608509" class="AnatomicStructure" value="Blood" score="1.00" ID="C12434">blood</Semaphore>, and due to that her <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>interrupted the <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment </Semaphore>for one week (unspecified dates). Patient reported that during this period she also underwent <Semaphore x="1804944" class="Procedure" value="Computed Tomography" score="1.00" ID="C17204">tomography </Semaphore>with contrast, she <Semaphore x="2950138" class="MedDRA LLT" value="Feeling abnormal" score="1.00" ID="10016322">felt very bad</Semaphore>, with a lot of <Semaphore x="1652857" class="Disease or Finding" value="Burn From Lead" score="1.00" ID="C61390">burning</Semaphore>. Patient mentioned she was presenting a <Semaphore x="2459410" class="Disease or Finding" value="Renal Cyst" score="1.00" ID="C3970"><Semaphore x="2892656" class="MedDRA LLT" value="Cyst" score="1.00" ID="10011732">cyst </Semaphore>in her <Semaphore x="2088512" class="AnatomicStructure" value="Kidney" score="1.00" ID="C12415">kidney</Semaphore></Semaphore>, which <Semaphore x="2763777" class="MedDRA LLT" value="Aspartate aminotransferase increased" score="1.00" ID="10003481">got increased</Semaphore>. She informed that <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>was aware, and she was waiting for exams to evaluate. Patient was hospitalized for 3 days (unspecified dates) due to <Semaphore x="3299128" class="MedDRA LLT" value="Urinary tract infection" score="1.00" ID="10046571"><Semaphore x="2088512" class="AnatomicStructure" value="Kidney" score="1.00" ID="C12415">urinary </Semaphore>infections </Semaphore>very strong. Laboratory data included unspecified exams in Sep2012, which included "<Semaphore x="3299128" class="MedDRA LLT" value="Urinary tract infection" score="1.00" ID="10046571"><Semaphore x="2088512" class="AnatomicStructure" value="Kidney" score="1.00" ID="C12415">urinary </Semaphore>infections </Semaphore>very strong" and <Semaphore x="1804944" class="Procedure" value="Computed Tomography" score="1.00" ID="C17204">tomography </Semaphore>with contrast, with unspecified <Semaphore x="1910095" class="Disease or Finding" value="Experimental Result" score="1.00" ID="C76125">results</Semaphore>. The action taken with <Semaphore x="545709" class="Medicine" value="Etanercept" score="0.99" ID="247557">etanercept </Semaphore>(powder and solvent for solution for <Semaphore x="2057274" class="AnatomicStructure" value="Injection Site" score="1.00" ID="C77680">injection </Semaphore>was <Semaphore x="1863447" class="Procedure" value="Dose Not Changed" score="1.00" ID="C49504">dose not changed </Semaphore>and the action taken for <Semaphore x="545709" class="Medicine" value="Etanercept" score="0.99" ID="247557">etanercept </Semaphore>solution for <Semaphore x="2057274" class="AnatomicStructure" value="Injection Site" score="1.00" ID="C77680">injection </Semaphore>in prefilled pen was <Semaphore x="1863447" class="Procedure" value="Dose Not Changed" score="1.00" ID="C49504">dose not changed </Semaphore>. The <Semaphore x="2353201" class="Disease or Finding" value="Outcome" score="1.00" ID="C20200">outcomes </Semaphore>of the events <Semaphore x="2008813" class="Disease or Finding" value="Headache" score="1.00" ID="C34661">headaches</Semaphore>, <Semaphore x="1609977" class="Disease or Finding" value="Bodily Pain" score="1.00" ID="C114901"><Semaphore x="3167117" class="MedDRA LLT" value="Pain" score="1.00" ID="10033371">pains </Semaphore>over the body</Semaphore>, secretion when <Semaphore x="2884277" class="MedDRA LLT" value="Cough" score="1.00" ID="10011224">coughing</Semaphore>, congested <Semaphore x="2320472" class="AnatomicStructure" value="Nose" score="1.00" ID="C12756">nose </Semaphore>and "a <Semaphore x="2459410" class="Disease or Finding" value="Renal Cyst" score="1.00" ID="C3970"><Semaphore x="2892656" class="MedDRA LLT" value="Cyst" score="1.00" ID="10011732">cyst </Semaphore>in her <Semaphore x="2088512" class="AnatomicStructure" value="Kidney" score="1.00" ID="C12415">kidney</Semaphore></Semaphore>, which <Semaphore x="2763777" class="MedDRA LLT" value="Aspartate aminotransferase increased" score="1.00" ID="10003481">got increased</Semaphore>" were not recovered. The <Semaphore x="2353201" class="Disease or Finding" value="Outcome" score="1.00" ID="C20200">outcomes </Semaphore>of the events left <Semaphore x="3280567" class="MedDRA LLT" value="Tinnitus" score="1.00" ID="10043882"><Semaphore x="1872213" class="AnatomicStructure" value="Ear" score="1.00" ID="C12394">ear </Semaphore>buzzing </Semaphore>which caused difficulty to listen, <Semaphore x="2757074" class="MedDRA LLT" value="Application site pain" score="1.00" ID="10003051"><Semaphore x="2365183" class="Disease or Finding" value="Pain" score="1.00" ID="C3303">pain </Semaphore>in the <Semaphore x="1541394" class="AnatomicStructure" value="Application Site" score="1.00" ID="C77676">application site</Semaphore></Semaphore>
    <Semaphore x="2756920" class="MedDRA LLT" value="Application site infection" score="1.00" ID="10049041">
     <Semaphore x="1541394" class="AnatomicStructure" value="Application Site" score="1.00" ID="C77676">, </Semaphore>"<Semaphore x="3299128" class="MedDRA LLT" value="Urinary tract infection" score="1.00" ID="10046571"><Semaphore x="2088512" class="AnatomicStructure" value="Kidney" score="1.00" ID="C12415">urinary </Semaphore>infections </Semaphore></Semaphore>very strong", "<Semaphore x="2950138" class="MedDRA LLT" value="Feeling abnormal" score="1.00" ID="10016322">felt very <Semaphore x="2950138" class="MedDRA LLT" value="Feeling abnormal" score="1.00" ID="10016322">bad</Semaphore>" and "patient felt </Semaphore>a lot of <Semaphore x="1652857" class="Disease or Finding" value="Burn From Lead" score="1.00" ID="C61390">burning</Semaphore>" were not provided were not provided.Follow up (08Jan2013): New information in follow up from a contactable patient includes Patient Data , Product data , additional con med, Event Data (five new events) and action taken.Follow up (16Jan2013): This follow up is being submitted to amend previously <Semaphore x="2640989" class="Procedure" value="Transmission Scan" score="1.00" ID="C94997">transmitted </Semaphore>information (action taken with <Semaphore x="528270" class="Medicine" value="Enbrel" score="0.87" ID="248473">Enbrel </Semaphore><Semaphore x="2425244" class="Disease or Finding" value="Progression of Multiple Myeloma or Plasma Cell Leukemia" score="1.00" ID="C70643">PFS </Semaphore>is <Semaphore x="1863447" class="Procedure" value="Dose Not Changed" score="1.00" ID="C49504">dose not changed</Semaphore>).</narrativeincludeclinical>
				<sendercomment>The events of feeling abnormal, burning sensation, and renal cyst have not been documented as listed in the Amgen package insert for etanercept. The event of urinary tract infection has been documented as listed in the Amgen package insert for etanercept.

Although a temporal association exists, it is not sufficient to establish, or rule out, a causal relationship between etanercept and the events reported in this case. As well, the causality is confounded by active rheumatoid arthritis, concomitant use of prednisone and methotrexate, and medical history of hypertension. Incomplete information regarding other risk factors does not permit a meaningful causality assessment. 

This individual case report does not change the safety profile of the product.</sendercomment>
			</summary>
		</patient>
	</safetyreport>
</ichicsr></original></faers>